Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
LBT Innovations Limited (AU:LBT)
ASX:LBT
Holding AU:LBT?
Track your performance easily
LBT Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week Range<AU$0.01 - AU$0.04
Previous CloseAU$0.02
Volume60.00K
Average Volume (3M)1.66M
Market Cap
AU$28.12M
Enterprise ValueAU$29.62M
Total Cash (Recent Filing)AU$2.79M
Total Debt (Recent Filing)AU$4.29M
Price to Earnings (P/E)―
Beta-1.44
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. Volume1,485,133
30 Day Avg. Volume1,662,558
Standard Deviation0.30
R-Squared0.02
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)4.79
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LBT Innovations Limited News
PremiumCompany Announcements
LBT Innovations Eyes Growth with APAS Sales Surge
PremiumCompany Announcements
LBT Innovations Expands ASX Listing with New Shares
PremiumCompany Announcements
LBT Innovations Secures US Sale with Bristol Myers Squibb
PremiumCompany Announcements
LBT Innovations Announces Option CessationsPremiumCompany Announcements
LBT Innovations Plans Major Securities Issue
PremiumCompany Announcements
LBT Innovations AGM: Name Change and Remuneration Plans
PremiumCompany Announcements
LBT Innovations Highlights APAS Tech at PDA Micro
PremiumCompany Announcements
LBT Innovations Announces Cessation of OptionsOptions Prices
Currently, No data available
---
Ownership Overview
LBT FAQ
What was LBT Innovations Limited’s price range in the past 12 months?
LBT Innovations Limited lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is LBT Innovations Limited’s market cap?
Currently, no data Available
When is LBT Innovations Limited’s upcoming earnings report date?
LBT Innovations Limited’s upcoming earnings report date is Mar 04, 2025 which is in 114 days.
How were LBT Innovations Limited’s earnings last quarter?
LBT Innovations Limited released its earnings results on Aug 28, 2024. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is LBT Innovations Limited overvalued?
According to Wall Street analysts LBT Innovations Limited’s price is currently Overvalued.
Does LBT Innovations Limited pay dividends?
LBT Innovations Limited does not currently pay dividends.
What is LBT Innovations Limited’s EPS estimate?
LBT Innovations Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LBT Innovations Limited have?
LBT Innovations Limited has 1,757,338,000 shares outstanding.
What happened to LBT Innovations Limited’s price movement after its last earnings report?
LBT Innovations Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -50%.
Which hedge fund is a major shareholder of LBT Innovations Limited?
Currently, no hedge funds are holding shares in AU:LBT
---
LBT Innovations Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:LBT Sentiment 83%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth AU$124.2K over
the Last 3 Months
the Last 3 Months
Fundamentals
Return on Equity
-322.69%
Trailing 12-Months
Asset Growth
7.61%
Trailing 12-Months
Company Description
LBT Innovations Limited
LBT Innovations Ltd is a designer of advanced technology solutions for the medical industry. Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process. Its second product, the Automated Plate Assessment System(APAS) is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis, and interpretation of microbiology culture plates following incubation.
---
Technical Analysis
Cyclopharm Limited
―
Race Oncology Ltd.
―
Resonance Health Ltd
―
Control Bionics Ltd.
―
---